Cellular actions of somatostatin on rat periaqueductal grey neurons in vitro.

Neurotensin inhibition of GABAergic transmission via mGluR-induced endocannabinoid signalling in rat periaqueductal grey. J Physiol (2009) 0.88

Pattern of Fos expression in the brain induced by selective activation of somatostatin receptor 2 in rats. Brain Res (2010) 0.86

Cholecystokinin exerts an effect via the endocannabinoid system to inhibit GABAergic transmission in midbrain periaqueductal gray. Neuropsychopharmacology (2011) 0.83

Somatostatin and corticotrophin releasing hormone cell types are a major source of descending input from the forebrain to the parabrachial nucleus in mice. Chem Senses (2014) 0.82

Modulation of the adaptive response to stress by brain activation of selective somatostatin receptor subtypes. Peptides (2012) 0.81

Central actions of somatostatin-28 and oligosomatostatin agonists to prevent components of the endocrine, autonomic and visceral responses to stress through interaction with different somatostatin receptor subtypes. Curr Pharm Des (2013) 0.76

Voltage-dependent modulation of N-type calcium channels by G-protein beta gamma subunits. Nature (1996) 4.01

Modulation of Ca2+ channels by G-protein beta gamma subunits. Nature (1996) 3.79

How opioids inhibit GABA-mediated neurotransmission. Nature (1997) 3.09

Classification and nomenclature of somatostatin receptors. Trends Pharmacol Sci (1995) 1.90

Presynaptic inhibitory action of opioids on synaptic transmission in the rat periaqueductal grey in vitro. J Physiol (1997) 1.57

Decay of prepulse facilitation of N type calcium channels during G protein inhibition is consistent with binding of a single Gbeta subunit. Proc Natl Acad Sci U S A (1998) 1.46

Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro. Mol Pharmacol (2000) 1.43

Hyperpolarization by opioids acting on mu-receptors of a sub-population of rat periaqueductal gray neurones in vitro. Br J Pharmacol (1994) 1.41

Opioid inhibition of rat periaqueductal grey neurones with identified projections to rostral ventromedial medulla in vitro. J Physiol (1996) 1.38

Selective opioid inhibition of small nociceptive neurons. Science (1995) 1.37

Actions of the ORL1 receptor ligand nociceptin on membrane properties of rat periaqueductal gray neurons in vitro. J Neurosci (1997) 1.17

Modulation of Ca2+ channel currents of acutely dissociated rat periaqueductal grey neurons. J Physiol (1998) 1.08

Somatostatin receptors on peripheral primary afferent terminals: inhibition of sensitized nociceptors. Pain (2001) 1.04

Inhibitory effect of somatostatin on the mechanosensitivity of articular afferents in normal and inflamed knee joints of the rat. Pain (1997) 0.95

Localization of the somatostatin receptor SST2A in rat brain using a specific anti-peptide antibody. J Neurosci (1996) 0.94

Immunohistochemical localization of the somatostatin SST2(A) receptor in the rat brain and spinal cord. Neuroscience (1997) 0.93

Somatostatin receptors in the central nervous system. Prog Neurobiol (1996) 0.92

Pharmacological characterisation of the somatostatin analogue TT-232: effects on neurogenic and non-neurogenic inflammation and neuropathic hyperalgesia. Naunyn Schmiedebergs Arch Pharmacol (2002) 0.91

Anti-inflammatory effect of synthetic somatostatin analogues in the rat. Br J Pharmacol (2001) 0.90

Modulation of high-voltage activated Ca2+ channels in the rat periaqueductal gray neurons by mu-type opioid agonist. J Neurophysiol (1997) 0.90

Spinal somatostatin superfusion in vivo affects activity of cat nociceptive dorsal horn neurons: comparison with spinal morphine. Neuroscience (1990) 0.89

Anti-nociceptive effect induced by somatostatin released from sensory nerve terminals and by synthetic somatostatin analogues in the rat. Neurosci Lett (2000) 0.89

Advances in understanding neuronal somatostatin receptors. Regul Pept (2000) 0.86

The effects of sandostatin and somatostatin on nociceptive transmission in the dorsal horn of the rat spinal cord. Neuropeptides (1992) 0.84

The effect of somatostatin on experimental inflammation in rats. Anesth Analg (1997) 0.84

Long-lasting antinociceptive effect of RC-160, a somatostatin analog, in mice and rats. Eur J Pharmacol (1991) 0.82

The localization of somatostatin receptor 1 (sst1) immunoreactivity in the rat brain using an N-terminal specific antibody. Neuroscience (1998) 0.82

Inhibition of spinal nociceptive neurons by microinjections of somatostatin into the nucleus raphe magnus and the midbrain periaqueductal gray of the anesthetized cat. Neurosci Lett (1995) 0.82

Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell (2010) 7.52

Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance. Pharmacol Rev (2013) 2.42

Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models. Br J Pharmacol (2006) 1.83

Opioid agonists have different efficacy profiles for G protein activation, rapid desensitization, and endocytosis of mu-opioid receptors. J Biol Chem (2003) 1.78

Conus venom peptide pharmacology. Pharmacol Rev (2012) 1.69

Mu-opioid receptor desensitization: is morphine different? Br J Pharmacol (2004) 1.64

Induction of delta-opioid receptor function in the midbrain after chronic morphine treatment. J Neurosci (2005) 1.35

Distinct cellular properties of identified dopaminergic and GABAergic neurons in the mouse ventral tegmental area. J Physiol (2011) 1.30

Capsaicin activation of glutamatergic synaptic transmission in the rat locus coeruleus in vitro. J Physiol (2002) 1.29

Modulation of GABA release during morphine withdrawal in midbrain neurons in vitro. Neuropharmacology (2003) 1.22

Antinociceptive tolerance revealed by cumulative intracranial microinjections of morphine into the periaqueductal gray in the rat. Pharmacol Biochem Behav (2006) 1.20

Actions of N-arachidonyl-glycine in a rat neuropathic pain model. Neuropharmacology (2007) 1.17

Pathobiology of dynorphins in trauma and disease. Front Biosci (2005) 1.17

Opioid tolerance in periaqueductal gray neurons isolated from mice chronically treated with morphine. Br J Pharmacol (2005) 1.16

GABA transporter currents activated by protein kinase A excite midbrain neurons during opioid withdrawal. Neuron (2005) 1.15

The multiple LIM domain-containing adaptor protein Hic-5 synaptically colocalizes and interacts with the dopamine transporter. J Neurosci (2002) 1.15

Two distinct mechanisms mediate acute mu-opioid receptor desensitization in native neurons. J Neurosci (2009) 1.13

Anandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neurons. Br J Pharmacol (2002) 1.11

Gingerols: a novel class of vanilloid receptor (VR1) agonists. Br J Pharmacol (2002) 1.11

Primary afferents with TRPM8 and TRPA1 profiles target distinct subpopulations of rat superficial dorsal horn neurones. Br J Pharmacol (2009) 1.09

Cellular morphine tolerance produced by βarrestin-2-dependent impairment of μ-opioid receptor resensitization. J Neurosci (2011) 1.09

Rostral ventromedial medulla neurons that project to the spinal cord express multiple opioid receptor phenotypes. J Neurosci (2002) 1.09

Excitation of rat colonic afferent fibres by 5-HT(3) receptors. J Physiol (2002) 1.07

Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to human. Br J Pharmacol (2011) 1.07

Glutamate spillover modulates GABAergic synaptic transmission in the rat midbrain periaqueductal grey via metabotropic glutamate receptors and endocannabinoid signaling. J Neurosci (2008) 1.04

Tolerance to the antinociceptive effect of morphine in the absence of short-term presynaptic desensitization in rat periaqueductal gray neurons. J Pharmacol Exp Ther (2010) 1.03

Serotonergic and nonserotonergic dorsal raphe neurons are pharmacologically and electrophysiologically heterogeneous. J Neurophysiol (2004) 1.02

Decavanadate, a P2X receptor antagonist, and its use to study ligand interactions with P2X7 receptors. Eur J Pharmacol (2006) 1.02

The role of opioid receptor phosphorylation and trafficking in adaptations to persistent opioid treatment. Neurosignals (2005) 1.01

Microinjection of the vehicle dimethyl sulfoxide (DMSO) into the periaqueductal gray modulates morphine antinociception. Brain Res (2008) 0.98

Actions of N-arachidonyl-glycine in a rat inflammatory pain model. Mol Pain (2007) 0.98

Prostaglandin E(2) inhibits calcium current in two sub-populations of acutely isolated mouse trigeminal sensory neurons. J Physiol (2002) 0.96

Analgesic tolerance to microinjection of the micro-opioid agonist DAMGO into the ventrolateral periaqueductal gray. Neuropharmacology (2007) 0.95

Identification of cells expressing somatostatin receptor 2 in the gastrointestinal tract of Sstr2 knockout/lacZ knockin mice. J Comp Neurol (2002) 0.95

Postsynaptic actions of substance P on rat periaqueductal grey neurons in vitro. Neuropharmacology (2005) 0.94

Extracellular signal-regulated kinase 1/2 activation counteracts morphine tolerance in the periaqueductal gray of the rat. J Pharmacol Exp Ther (2009) 0.93

Drug-induced GABA transporter currents enhance GABA release to induce opioid withdrawal behaviors. Nat Neurosci (2011) 0.93

Muscarinic modulation of synaptic transmission via endocannabinoid signalling in the rat midbrain periaqueductal gray. Mol Pharmacol (2008) 0.93

Contribution of dopamine receptors to periaqueductal gray-mediated antinociception. Psychopharmacology (Berl) (2009) 0.93

ATP potentiates neurotransmission in the rat trigeminal subnucleus caudalis. Neuroreport (2006) 0.92

Somatostatin receptor 2 knockout/lacZ knockin mice show impaired motor coordination and reveal sites of somatostatin action within the striatum. Eur J Neurosci (2003) 0.92

Inflammation reduces the contribution of N-type calcium channels to primary afferent synaptic transmission onto NK1 receptor-positive lamina I neurons in the rat dorsal horn. J Physiol (2007) 0.92

Presynaptic gating of excitation in the dorsal raphe nucleus by GABA. Proc Natl Acad Sci U S A (2013) 0.90

Trishomocubanes: novel sigma ligands modulate cocaine-induced behavioural effects. Eur J Pharmacol (2006) 0.89

Opioid-related (ORL1) receptors are enriched in a subpopulation of sensory neurons and prolonged activation produces no functional loss of surface N-type calcium channels. J Physiol (2012) 0.89

Menthol enhances phasic and tonic GABAA receptor-mediated currents in midbrain periaqueductal grey neurons. Br J Pharmacol (2014) 0.88

Substance P drives endocannabinoid-mediated disinhibition in a midbrain descending analgesic pathway. J Neurosci (2009) 0.88

Cellular actions of opioids on periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1. Br J Pharmacol (2003) 0.88

Intermittent dosing prolongs tolerance to the antinociceptive effect of morphine microinjection into the periaqueductal gray. Brain Res (2005) 0.87

Learning-related translocation of δ-opioid receptors on ventral striatal cholinergic interneurons mediates choice between goal-directed actions. J Neurosci (2013) 0.87

Multiple metabotropic glutamate receptor subtypes modulate GABAergic neurotransmission in rat periaqueductal grey neurons in vitro. Neuropharmacology (2004) 0.87

Probing N-methyl-D-aspartate receptor desensitization with the substituted-cysteine accessibility method. Mol Pharmacol (2005) 0.87

Multiple mechanisms of microglia: a gatekeeper's contribution to pain states. Exp Neurol (2012) 0.87

N-arachidonyl-glycine modulates synaptic transmission in superficial dorsal horn. Br J Pharmacol (2010) 0.86

Sumatriptan inhibits synaptic transmission in the rat midbrain periaqueductal grey. Mol Pain (2008) 0.86

Opioid receptor modulation of GABAergic and serotonergic spinally projecting neurons of the rostral ventromedial medulla in mice. J Neurophysiol (2011) 0.86

Expression of mRNA and functional alpha(1)-adrenoceptors that suppress the GIRK conductance in adult rat locus coeruleus neurons. Br J Pharmacol (2002) 0.85

Actions of the endocannabinoid transport inhibitor AM404 in neuropathic and inflammatory pain models. Clin Exp Pharmacol Physiol (2007) 0.85

Differential development of antinociceptive tolerance to morphine and fentanyl is not linked to efficacy in the ventrolateral periaqueductal gray of the rat. J Pain (2012) 0.85

Functional characterization of rhesus embryonic stem cell-derived serotonin neurons. Exp Biol Med (Maywood) (2010) 0.84

Cholecystokinin exerts an effect via the endocannabinoid system to inhibit GABAergic transmission in midbrain periaqueductal gray. Neuropsychopharmacology (2011) 0.83

Differential control of opioid antinociception to thermal stimuli in a knock-in mouse expressing regulator of G-protein signaling-insensitive Gαo protein. J Neurosci (2013) 0.82

Somatostatin and nociceptin inhibit neurons in the central nucleus of amygdala that project to the periaqueductal grey. Neuropharmacology (2010) 0.82

Glutamate transporter dysfunction associated with nerve injury-induced pain in mice. J Neurophysiol (2011) 0.82

A sensitive membrane-targeted biosensor for monitoring changes in intracellular chloride in neuronal processes. PLoS One (2012) 0.82

Behavioral consequences of delta-opioid receptor activation in the periaqueductal gray of morphine tolerant rats. Neural Plast (2009) 0.81

Effect of the cannabinoid ajulemic acid on rat models of neuropathic and inflammatory pain. Neurosci Lett (2005) 0.81

Prolonged stimulation of μ-opioid receptors produces β-arrestin-2-mediated heterologous desensitization of α(2)-adrenoceptor function in locus ceruleus neurons. Mol Pharmacol (2012) 0.80

MrIC, a novel α-conotoxin agonist in the presence of PNU at endogenous α7 nicotinic acetylcholine receptors. Biochemistry (2013) 0.80

Developmental changes in the alpha-adrenergic responses of rat periaqueductal grey neurons. Neuroreport (2003) 0.79

Glutamate modulation of antinociception, but not tolerance, produced by morphine microinjection into the periaqueductal gray of the rat. Brain Res (2009) 0.79

Dissociation of μ- and δ-opioid inhibition of glutamatergic synaptic transmission in superficial dorsal horn. Mol Pain (2010) 0.79

Chemical synthesis and structure of the prokineticin Bv8. Chembiochem (2010) 0.79

GABAergic transmission and enhanced modulation by opioids and endocannabinoids in adult rat rostral ventromedial medulla. J Physiol (2014) 0.78

μ-Opioid receptor activation and noradrenaline transport inhibition by tapentadol in rat single locus coeruleus neurons. Br J Pharmacol (2014) 0.78

Enhanced c-Fos in periaqueductal grey GABAergic neurons during opioid withdrawal. Neuroreport (2005) 0.78

Chronic inflammatory pain prevents tolerance to the antinociceptive effect of morphine microinjected into the ventrolateral periaqueductal gray of the rat. J Pain (2013) 0.78

Endocannabinoid modulation by FAAH and monoacylglycerol lipase within the analgesic circuitry of the periaqueductal grey. Br J Pharmacol (2014) 0.77

Characterization of bradykinin-induced prostaglandin E2 release from cultured rat trigeminal ganglion neurones. Eur J Pharmacol (2003) 0.76

Postsynaptic mGluR mediated excitation of neurons in midbrain periaqueductal grey. Neuropharmacology (2012) 0.76

Columnar distribution of catecholaminergic neurons in the ventrolateral periaqueductal gray and their relationship to efferent pathways. Synapse (2012) 0.76

Chronic psychostimulant exposure to adult, but not periadolescent rats reduces subsequent morphine antinociception. Pharmacol Biochem Behav (2012) 0.75

Humanizing mice: catching up with elusive B1 receptors. Br J Pharmacol (2005) 0.75